GOSSAMER BIO, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $29.1M | $121.5M | $183.4M |
| FY2022 | $12.0M | $12.1M | $112.0M |
| FY2023 | $814.0K | $62.8M | $32.1M |
| FY2024 | $0 | $29.5M | $46.1M |
| FY2025 | — | $-122.8M | $37.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $29.1M | $121.5M | $183.4M |
| FY2022 | $12.0M | $12.1M | $112.0M |
| FY2023 | $814.0K | $62.8M | $32.1M |
| FY2024 | $0 | $29.5M | $46.1M |
| FY2025 | — | $-122.8M | $37.7M |